CbiN operates as part of an ABC transporter complex (CbiN-O-M), where it binds extracellular cobalt and transfers it to the transmembrane subunits (CbiO-M). This mechanism aligns with the general ABC transporter paradigm:
Substrate Capture: CbiN adopts a closed conformation upon cobalt binding, stabilizing the substrate in a high-affinity state .
ATP Hydrolysis: The nucleotide-binding domains (NBDs) of the transporter hydrolyze ATP, driving conformational changes that translocate cobalt across the membrane .
Cobalt is essential for methanogenesis, as it serves as a cofactor in enzymes like methyl-coenzyme M reductase (Mcr) .
Commercially available recombinant CbiN is produced in E. coli and purified via affinity chromatography. Key specifications include:
CbiN is utilized in biochemical and structural studies to investigate ABC transporter mechanisms. Notable applications include:
Biochemical Assays: ELISA kits (e.g., CSB-CF389453MNP) enable quantification of CbiN in experimental samples, aiding studies on transporter regulation .
Structural Biology: Crystallographic studies of related ABC transporters (e.g., Archaeoglobus fulgidus ModBC) provide insights into substrate recognition and ATP-dependent conformational changes .
The two recombinant CbiN variants differ in sequence and gene locus:
| Feature | Variant A4FW42 (MmarC5_0096) | Variant A9A9I2 (MmarC6_1192) |
|---|---|---|
| AA Sequence | ILILAPLIMYS...IGAIIIGYFF | ILTLAPLIMYS...IGAMIIGYFF |
| C-terminal Motif | EDKN | DDKN |
| Accession | A4FW42 | A9A9I2 |
These differences may influence substrate affinity or binding kinetics, though experimental validation is required .
KEGG: mmq:MmarC5_0096
STRING: 402880.MmarC5_0096
CbiN is a cobalt transport protein in Methanococcus maripaludis that plays a crucial role in cobalt uptake, which is essential for vitamin B12 biosynthesis and methanogenic metabolism. The protein consists of 97 amino acids with the sequence: MEFKHVLMILGVIILILAPLIMYSGLGEDEGYFGGADGAAGDLIMEISPNYEPWFEPFWEPPSGEIESLLFALQAAIGAIIIGYFFGYNKAKYEDKN . As a transmembrane protein, CbiN functions as part of a larger cobalt transport complex that facilitates the selective uptake of cobalt ions across the cell membrane. This process is vital for the archaeon's survival in environments where cobalt availability may be limited.
Recombinant CbiN protein production follows standard recombinant protein expression protocols with specific optimizations for archaeal proteins. The process involves:
DNA cloning: The cbiN gene is isolated and inserted into an expression vector at a specific location using restriction enzymes .
Transformation: The recombinant DNA molecule containing the cbiN gene is introduced into host cells, typically E. coli for ease of manipulation and high yield potential .
Selection and expression: Transformed cells are selected using antibiotic resistance markers incorporated in the vector. Only cells that have successfully integrated the recombinant DNA will survive in the presence of the specific antibiotic .
Protein production: The host cells express the recombinant CbiN protein through transcription and translation of the inserted gene .
Purification: The expressed protein is typically fused with a His-tag to facilitate purification using affinity chromatography methods .
This expression in E. coli rather than the native archaeon allows for higher yield and easier manipulation of growth conditions.
For optimal stability and activity, recombinant CbiN protein should be stored following these guidelines:
Aliquoting is necessary to prevent protein degradation during repeated freeze-thaw cycles .
Repeated freezing and thawing should be avoided as it can lead to protein denaturation and loss of functionality .
Proper storage is critical for maintaining protein structure and function, especially for transmembrane proteins like CbiN that may be prone to aggregation when removed from their native membrane environment.
CRISPR/Cas12a technology offers a powerful approach for investigating CbiN function through precise genetic manipulation. The methodology involves:
Design of guide RNA (gRNA): Specific gRNAs targeting the cbiN gene or its regulatory regions should be designed with consideration of M. maripaludis genome characteristics.
Vector construction: The gRNA and Cas12a gene can be expressed using a vector like pMM002P, which has been successfully used in M. maripaludis .
Transformation: Introduction of the CRISPR/Cas12a system into M. maripaludis using appropriate transformation protocols.
Homology-directed repair: For gene editing, homology arms of 500-1000 bp should be provided to direct the repair of Cas12a-induced double-strand breaks . This is particularly important as M. maripaludis lacks efficient non-homologous end-joining (NHEJ) machinery .
Selection and verification: Transformed cells can be selected, and genome editing can be verified using restriction digestion of PCR products or sequencing .
When implementing this approach, researchers should be aware that M. maripaludis has an active PstI restriction modification system that can digest foreign DNA containing unmethylated PstI sites, potentially reducing transformation efficiency by 1.6-3.4 fold per PstI site .
The choice of expression system significantly impacts the functional studies of CbiN. Here's a methodological comparison:
| Expression System | Advantages | Limitations | Recommended Applications |
|---|---|---|---|
| E. coli | High yield, ease of manipulation, well-established protocols | Potential improper folding of archaeal proteins, lack of archaeal-specific modifications | Initial structural studies, antibody production |
| Native M. maripaludis | Authentic protein folding and modifications, natural membrane environment | Lower yield, more complex cultivation conditions | Functional assays, interaction studies |
| Cell-free systems | Rapid expression, avoids toxicity issues | May lack proper membrane environment for transmembrane proteins | Preliminary functional screening |
For promoter selection in M. maripaludis, several options have been evaluated with different strengths:
Strong constitutive promoters: Pmcr, Pmcr_JJ, Pfla_JJ, PglnA, and Pmtr show strong expression under various growth conditions .
Substrate-dependent promoters: PhdrC1 shows expression only in formate-containing media, offering a conditional expression option .
Regulated promoters: Pnif is normally repressed by nitrogen regulatory protein R, providing an option for controlled expression .
The selection of an appropriate promoter should be based on the specific requirements of the experimental design, including the desired expression level and timing.
To elucidate CbiN's functional role, a multi-faceted experimental approach is recommended:
Knockout/knockdown studies: Generate cbiN deletion mutants using CRISPR/Cas12a genome editing and assess:
Growth rates in cobalt-limited media
Vitamin B12 production levels
Cobalt uptake rates using radioactive 60Co
Complementation assays: Reintroduce wild-type or mutant cbiN genes to knockout strains to verify phenotype restoration.
Protein-protein interaction studies:
Co-immunoprecipitation to identify binding partners
Bacterial two-hybrid assays to confirm direct interactions
Crosslinking experiments to capture transient interactions
Transport assays:
Membrane vesicle preparations with reconstituted CbiN
Measurement of cobalt uptake under various conditions
Competition assays with other divalent metals
Structural studies:
Circular dichroism to assess secondary structure
X-ray crystallography or cryo-EM for detailed structural information
These approaches should be implemented systematically, with appropriate controls to account for the polyploid nature of M. maripaludis and potential pleiotropic effects of cbiN manipulation.
Designing robust experiments to measure CbiN-mediated cobalt transport requires careful consideration of several methodological aspects:
Preparation of experimental system:
Purify recombinant CbiN with intact structural integrity
Reconstitute CbiN in liposomes or proteoliposomes
Prepare membrane vesicles from CbiN-expressing cells
Transport assay setup:
Establish baseline conditions: optimal pH, temperature, and ionic strength
Prepare radioactive 60Co or fluorescent cobalt probes
Set up appropriate negative controls (liposomes without CbiN, inactive CbiN mutants)
Measurement parameters:
Design time-course measurements to determine transport kinetics
Establish concentration gradients to determine Km and Vmax values
Include competition assays with other divalent cations (Ni2+, Zn2+, Fe2+)
Data collection and analysis:
Validation approaches:
Confirm CbiN-dependency through selective inhibition
Verify results using genetic approaches (cbiN knockout/complementation)
Perform control experiments with related transport proteins
This experimental design allows for rigorous quantification of CbiN-mediated cobalt transport while controlling for potential confounding factors.
For comparing transport rates between conditions:
For kinetic data analysis:
Non-linear regression for determining Michaelis-Menten parameters
Lineweaver-Burk or Eadie-Hofstee transformations for visualizing kinetic data
Bootstrap resampling for robust parameter estimation
For dose-response relationships:
Hill equation fitting for cooperative binding
IC50 determination for inhibition studies
Curve comparison tests to evaluate differences between conditions
For presenting variation in data:
For multivariate analysis:
Principal component analysis for identifying patterns in complex datasets
Cluster analysis for grouping similar experimental conditions
Machine learning approaches for predictive modeling of transport activity
When reporting results, include measures of central tendency (mean) and measures of variation (range or standard deviation), as appropriate for the experimental design .
M. maripaludis, like many archaea, possesses multiple genome copies (polyploidy), which presents unique challenges for genetic studies of CbiN. Researchers should implement these methodological approaches:
Complete genome editing verification:
Use restriction digestion analysis with engineered restriction sites (e.g., NotI) to distinguish between wild-type and edited genome copies
Perform quantitative PCR to determine the ratio of wild-type to modified genome copies
Implement serial passages with selection to enrich for cells with complete genome modification
Phenotypic analysis strategies:
Establish dose-response relationships between the proportion of modified genomes and observed phenotypes
Use conditional expression systems to overcome partial modification challenges
Implement single-cell analysis techniques to correlate genotype with phenotype
Data analysis considerations:
Account for heterogeneity in cell populations when interpreting bulk measurements
Develop mathematical models that incorporate varying levels of gene expression
Use appropriate statistical methods that account for increased variability
This methodological framework enables researchers to navigate the complexities of polyploidy when investigating CbiN function in M. maripaludis.
Distinguishing direct from indirect effects in CbiN knockout studies requires a systematic approach:
Complementation analysis:
Reintroduce wild-type cbiN on a plasmid under native or controlled promoters
Create point mutations in functional domains to identify specific requirements
Implement dose-dependent expression systems to establish causality
Temporal analysis:
Use time-course experiments to identify primary (immediate) versus secondary effects
Implement pulse-chase experiments with radioactive cobalt to track transport kinetics
Analyze gene expression changes over time after CbiN depletion
Metabolomic profiling:
Compare metabolite profiles between wild-type and cbiN mutants
Focus on vitamin B12-dependent pathways and cobalt-utilizing enzymes
Track isotopically labeled cobalt through metabolic networks
Epistasis analysis:
Create double knockouts with genes in related pathways
Establish genetic interaction networks to position CbiN in cellular processes
Implement synthetic lethality screens to identify functional redundancies
Direct biochemical verification:
Reconstitute purified CbiN in artificial membrane systems
Perform in vitro transport assays under controlled conditions
Use structure-function analysis to validate specific transport mechanisms
This comprehensive approach helps delineate the direct role of CbiN in cobalt transport from secondary effects resulting from vitamin B12 deficiency or other metabolic perturbations.
Optimizing CRISPR/Cas12a for efficient editing of cbiN requires attention to several key parameters:
Guide RNA design optimization:
Select guide RNAs with minimal off-target potential in the M. maripaludis genome
Target PAM sites (TTTV for LbCas12a) that are accessible in the archaeal chromatin
Avoid regions with secondary structures that might impede Cas12a binding
Expression system considerations:
Homology-directed repair optimization:
Transformation protocol refinements:
Optimize transformation conditions to maximize uptake of the CRISPR/Cas12a components
Consider methylation of the transformation DNA to protect against restriction
Implement recovery steps that allow for efficient homology-directed repair
Screening and validation:
This optimized approach takes advantage of the CRISPR/Cas12a system's efficiency while addressing the specific challenges of genetic manipulation in M. maripaludis.
Integrating proteomics and transcriptomics provides powerful insights into CbiN function:
Comparative transcriptomics approaches:
RNA-seq analysis of wild-type vs. cbiN knockout strains
Identification of differentially expressed genes in cobalt-limited conditions
Time-course analysis after cobalt addition or depletion
Correlation of expression patterns with vitamin B12-dependent pathways
Proteomics methodologies:
Quantitative proteomics (iTRAQ, TMT, or label-free) to identify protein abundance changes
Phosphoproteomics to detect signaling pathways affected by cobalt availability
Protein-protein interaction studies using proximity labeling (BioID, APEX)
Membrane proteomics to identify co-localized transport components
Integrative data analysis:
Correlation of transcriptomic and proteomic changes
Pathway enrichment analysis to identify affected cellular processes
Network analysis to position CbiN within the cobalt homeostasis network
Machine learning approaches to predict functional relationships
Validation experiments:
Targeted gene expression analysis by qRT-PCR
Western blotting for key proteins identified in -omics studies
Metabolic flux analysis to confirm functional consequences
This integrative approach provides a systems-level understanding of CbiN's role in cobalt transport and its impact on broader cellular metabolism, particularly vitamin B12-dependent processes.